The role of microalbuminuria and insulin resistance as significant risk factors for white matter lesions in Japanese type 2 diabetic patients

References

• Pantoni L, Garcia JH. The significance of cerebral white matter abnormalities 100 years after Binswanger's report. Stroke 1995; 26: 1293–301
   PubMed Web of Science ®Google Scholar
• Wong TY, Klein R, Sharrett AR, . Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA 2002; 288: 67–74
   PubMed Web of Science ®Google Scholar
• Vermeer SE, Hollander M, van Dijk EJ, . Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 2003; 34: 1126–9
   PubMed Web of Science ®Google Scholar
• Longstreth WT Jr, Manolio TA, Arnold A, . Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996; 27: 1274–82
   PubMed Web of Science ®Google Scholar
• Schmidt R, Launer LJ, Nilsson LG, . CASCADE Consortium. A magnetic resonance imaging of midlife blood pressure to late-life cognitive decline and brain morphology. Diabetes 2004; 53: 687–92
   PubMed Web of Science ®Google Scholar
• Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: a systematic overview of the literature. Arch Intern Med 1997; 157: 1413–18
   PubMed Web of Science ®Google Scholar
• Mogensen CE. Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas. Diabetologia 1999; 42: 263–85
   PubMed Web of Science ®Google Scholar
• Gerstein HC, Mann JF, Yi Q, . Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286: 421–6
   PubMed Web of Science ®Google Scholar
• de Zeeuw D, Remuzzi G, Parving HH, . Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 2004; 110: 921–7
   PubMed Web of Science ®Google Scholar
• Vupputuri S, Shoham DA, Hogan SL, . Microalbuminuria, peripheral artery disease, and cognitive function. Kidney Int 2008; 73: 341–6
   PubMed Web of Science ®Google Scholar
• Reaven GM. Role of insulin resistance in human disease. Diabetes 1998; 37: 1595–607
   Google Scholar
• DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173–94
   PubMed Web of Science ®Google Scholar
• Jeppesen J, Hansen TW, Rasmussen S, . Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study. J Am Coll Cardiol 2007; 49: 2112–19
   PubMed Web of Science ®Google Scholar
• Liao D, Sloan RP, Cascio WE, . Multiple metabolic syndrome is associated with lower heart rate variability. The Atherosclerosis Risk in Communities Study. Diabetes Care 1998; 21: 2116–22
   PubMed Web of Science ®Google Scholar
• Mancia G, De Backer G, Dominiczak A, . ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension. J Hypertens 2007; 25: 1751–62
   PubMed Web of Science ®Google Scholar
• Friedwald WT, Levi RI, Fredrickson DC. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the ultracentrifuge. Clin Chem 1972; 18: 499–502
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–19
   PubMed Web of Science ®Google Scholar
• Taniguchi A, Fukushima M, Sakai M, . Remnant-like particle cholesterol, triglyceride, and insulin resistance in nonobese Japanese type 2 diabetic patients. Diabetes Care 2000; 23: 1766–9
   PubMed Web of Science ®Google Scholar
• Taniwaki H, Nishizawa Y, Kawagishi T, . Decrease in glomerular filtration rate in Japanese patients with type 2 diabetes is linked to atherosclerosis. Diabetes Care 1998; 21: 1848–55
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Nephropathy in diabetes. Diabetes Care 2004; 27: S79–83
   PubMedGoogle Scholar
• Breteler MM, van Swieten JC, Bots ML, . Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 1994; 44: 1246–52
   PubMed Web of Science ®Google Scholar
• Shimada K, Kawamoto A, Matsubayashi K, . Silent cerebrovascular disease in the elderly. Correlation with ambulatory pressure. Hypertension 1990; 16: 692–9
   PubMed Web of Science ®Google Scholar
• Sierra C, de la Sierra A, Mercader J, . Silent cerebral white matter lesions in middle-aged essential hypertensive patients. J Hypertens 2002; 20: 519–24
   PubMed Web of Science ®Google Scholar
• Goligorsky MS, Chen J, Brodsky S. Workshop: endothelial cell dysfunction leading to diabetic nephropathy: focus on nitric oxide. Hypertension 2001; 37: 744–8
   PubMed Web of Science ®Google Scholar
• Stout RW. Insulin and atheroma: 20-yr perspective. Diabetes Care 1990; 13: 631–54
   PubMed Web of Science ®Google Scholar
• Kuboki K, Jiang ZY, Takahara N, . Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation 2000; 101: 676–81
   PubMed Web of Science ®Google Scholar
• Steinberg HO, Paradisi G, Hook G, . Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes 2000; 49: 1231–8
   PubMed Web of Science ®Google Scholar
• Arcaro G, Gretti A, Balzano S, . Insulin causes endothelial dysfunction in humans: sites and mechanisms. Circulation 2002; 105: 576–82
   PubMed Web of Science ®Google Scholar
• Wada M, Nagasawa H, Kurita K, . Microalbuminuria is a risk factor for cerebral small vessel disease in community-based elderly subjects. J Neurol Sci 2007; 255: 27–34
   PubMed Web of Science ®Google Scholar
• Gavras HP. Issues in hypertension: drug tolerability and special populations. Am J Hypertens 2001; 14: 231–6S
   PubMed Web of Science ®Google Scholar
• Lender D, Arauz-Pacheco C, Breen L, Mora-Mora P, . A double blind comparison of the effects of amlodipine and enalapril on insulin sensitivity in hypertensive patients. Am J Hypertens 1999; 12: 298–303
   PubMed Web of Science ®Google Scholar
• Bianchi S, Bigazzi R, Baldari G, . Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens 1994; 7: 23–9
   PubMed Web of Science ®Google Scholar
• Anan F, Takahashi N, Ooie T, . Role of insulin resistance in nondipper essential hypertensive patients. Hypertens Res 2003; 26: 669–76
   PubMed Web of Science ®Google Scholar